Am J Med

1. CYMBAL M, Chatterjee A, Baggott B, Auron M, et al
   Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.
   Am J Med. 2024;137:571-576.
   

   >> Share

   
   
2. ALPERT JS
   Leprosy in Literature and Art: The Covenant of Water.
   Am J Med. 2024;137:559-560.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

3. CRABBE A
   Moving Beyond Antibiotics: Exploring the Potential of an Anti-Virulence Monoclonal Antibody Against Pseudomonas aeruginosa in Bronchiectasis.
   Am J Respir Crit Care Med. 2024 May 23. doi: 10.1164/rccm.202405-0974.
   

   >> Share

   
   
4. LONG MB, Gilmour A, Kehl M, Tabor D, et al
   A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis.
   Am J Respir Crit Care Med. 2024 May 16. doi: 10.1164/rccm.202308-1403.
   

   >> Share

   
   
5. MCSHANE PJ, Brunton AE, Choate R, Marmor M, et al
   The Impact of Tobacco Smoking in Bronchiectasis: Data from the United States Bronchiectasis and NTM Research Registry.
   Am J Respir Crit Care Med. 2024 May 7. doi: 10.1164/rccm.202402-0466.
   

   >> Share

   
   
6. AKSAMIT TR, Locantore N, Addrizzo-Harris D, Ali J, et al
   Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
   Am J Respir Crit Care Med. 2024 Apr 26. doi: 10.1164/rccm.202307-1165.
   

   >> Share

   
   
7. MAC AOGAIN M, Xaverius Ivan F, Jaggi TK, Richardson H, et al
   Airway 'Resistotypes' and Clinical Outcomes in Bronchiectasis.
   Am J Respir Crit Care Med. 2024 Jan 25. doi: 10.1164/rccm.202306-1059.
   

   >> Share

   
   

   
   Am J Trop Med Hyg

8. HOWES M, Currie BJ
   Melioidosis and Activation from Latency: The "Time Bomb" Has Not Occurred.
   Am J Trop Med Hyg. 2024;111:156-160.
   

   >> Share

   
   
9. TRIPATHY S, Jamwal A, Varghese G, Sarawat D, et al
   Characterization of Leuconostoc lactis Bacteremia during a 2-year Study at a Tertiary Care Center in North India-An Observational Analysis.
   Am J Trop Med Hyg. 2024;111:129-131.
   

   >> Share

   
   
10. ROTINI G, de Mangou A, Combe A, Jabot J, et al
    Case Report: Severe Community-Acquired Pneumonia in Reunion Island due to Acinetobacter baumannii.
    Am J Trop Med Hyg. 2024;111:136-140.
    

    >> Share

    
    
11. CASTRO-RODRIGUEZ B, Cazar-Ramos C, Franco-Sotomayor G, Cardenas-Franco GE, et al
    The Impact of the Mycobacterium tuberculosis RDRio Subfamily on Multidrug-Resistant Tuberculosis in Latin America: A Comprehensive Review.
    Am J Trop Med Hyg. 2024 Jul 2:tpmd240073. doi: 10.4269/ajtmh.24-0073.
    

    >> Share

    
    
12. NASH SD, Sata E, Chernet A, Gonzalez TA, et al
    The Epidemiology of Ocular Chlamydia trachomatis Infection within Districts Persistently Endemic for Trachoma in Amhara, Ethiopia.
    Am J Trop Med Hyg. 2024 Jul 2:tpmd230876. doi: 10.4269/ajtmh.23-0876.
    

    >> Share

    
    
13. NAKAZAKI JCF, Suito M
    Disseminated Tuberculosis.
    Am J Trop Med Hyg. 2024 Jul 2:tpmd240132. doi: 10.4269/ajtmh.24-0132.
    

    >> Share

    
    
14. VARGHESE G, Sarawat D, Jamwal A, Patel SS, et al
    Case Series: Microbacterium aurum Bacteremia in Immunosuppressed Patients-An Emerging Threat.
    Am J Trop Med Hyg. 2024;111:132-135.
    

    >> Share

    
    
15. LIM C, Klaytong P, Hantrakun V, Rangsiwutisak C, et al
    Automating the Generation of Notifiable Bacterial Disease Reports: Proof-of-Concept Study and Implementation in Six Hospitals in Thailand.
    Am J Trop Med Hyg. 2024;111:151-155.
    

    >> Share

    
    
16. HO-PALMA AC, Gonzales-Gustavson E, Quispe E, Crotta M, et al
    Salmonella in Chicken and Pork Meat as a Likely Major Contributor to Foodborne Illness in Peru.
    Am J Trop Med Hyg. 2024;111:141-150.
    

    >> Share

    
    

    
    Antimicrob Agents Chemother

17. BEREDAKI M-I, Arendrup MC, Pournaras S, Meletiadis J, et al
    Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrob Agents Chemother. 2024 Jul 3:e0022524. doi: 10.1128/aac.00225.
    

    >> Share

    
    

    
    BMC Neurol

18. DAMBIETZ C, Heming M, Brix TJ, Schulte-Mecklenbeck A, et al
    Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy.
    BMC Neurol. 2024;24:229.
    

    >> Share

    
    

    
    BMC Pediatr

19. DILAGHI E, Felici E, Lahner E, Pilozzi E, et al
    Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter study.
    BMC Pediatr. 2024;24:417.
    

    >> Share

    
    

    
    Clin Infect Dis

20. WANG MS, Li-Hunnam J, Chen YL, Gilmour B, et al
    Conversion or reversion of interferon gamma release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis. 2024 Jul 2:ciae357. doi: 10.1093.
    

    >> Share

    
    
21. KIMUDA S, Kwizera R, Dai B, Kigozi E, et al
    Comparison of early fungicidal activity and mortality between daily liposomal amphotericin B and daily amphotericin B deoxycholate among patients with HIV-associated cryptococcal meningitis.
    Clin Infect Dis. 2024 Jun 29:ciae326. doi: 10.1093.
    

    >> Share

    
    

    
    Curr Microbiol

22. YOU Y, Xiao J, Chen J, Li Y, et al
    Integrated Information for Pathogenicity and Treatment of Spiroplasma.
    Curr Microbiol. 2024;81:252.
    

    >> Share

    
    

    
    Diagn Microbiol Infect Dis

23. DRAGOI AL, Nemes RM
    A unique case of double meningitis with enterovirus and reactivated varicella-zoster virus in a male teenager.
    Diagn Microbiol Infect Dis. 2024;110:116409.
    

    >> Share

    
    
24. TANG X, Yang L, Zhang R, Fang H, et al
    Non-invasive detection of Aspergillosis in ventilated patients: Galactomannan analysis in exhaled breath.
    Diagn Microbiol Infect Dis. 2024;110:116420.
    

    >> Share

    
    

    
    Eur J Clin Microbiol Infect Dis

25. FERRER J, Gimenez E, Carretero D, Clari MA, et al
    Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis.
    Eur J Clin Microbiol Infect Dis. 2024 Jul 3. doi: 10.1007/s10096-024-04880.
    

    >> Share

    
    

    
    Infect Immun

26. YANG C, Robledo-Avila FH, Partida-Sanchez S, Montgomery CP, et al
    alpha-Hemolysin-mediated endothelial injury contributes to the development of Staphylococcus aureus-induced dermonecrosis.
    Infect Immun. 2024 Jul 2:e0013324. doi: 10.1128/iai.00133.
    

    >> Share

    
    

    
    J Antimicrob Chemother

27. IVANOVA M, Ovsepian A, Leekitcharoenphon P, Seyfarth AM, et al
    Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
    J Antimicrob Chemother. 2024;79:1657-1667.
    

    >> Share

    
    
28. LEE YL, Wang WY, Ko WC, Hsueh PR, et al
    Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021.
    J Antimicrob Chemother. 2024 May 17:dkae140. doi: 10.1093.
    

    >> Share

    
    
29. MILLS RO, Dadzie I, Le-Viet T, Baker DJ, et al
    Genomic diversity and antimicrobial resistance in clinical Klebsiella pneumoniae isolates from tertiary hospitals in Southern Ghana.
    J Antimicrob Chemother. 2024 May 16:dkae123. doi: 10.1093.
    

    >> Share

    
    
30. BIGHI N, Freitas F, Morgado S, Cipriano R, et al
    Deciphering the accessory genome of a novel Klebsiella pneumoniae lineage in the Brazilian Amazon region and its potential contribution to the emergence of a high-risk clone.
    J Antimicrob Chemother. 2024;79:1709-1711.
    

    >> Share

    
    
31. CHEN PJ, Tan MC, Huang WC, Hsu SY, et al
    The individual contributions of blaB, blaGOB and blaCME on MICs of beta-lactams in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2024;79:1577-1580.
    

    >> Share

    
    
32. SUBBARAO S, Boyd SE, Basarab M, Riley P, et al
    Comment on: In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019).
    J Antimicrob Chemother. 2024;79:1715-1716.
    

    >> Share

    
    
33. TAYSI MR, Ocal D, Cicek Senturk G, Caliskan E, et al
    Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality.
    J Antimicrob Chemother. 2024;79:1540-1546.
    

    >> Share

    
    
34. MENENDEZ ALVARADO LR, Margulis Landayan A, Williams KN, Frederick CM, et al
    Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections.
    J Antimicrob Chemother. 2024 May 8:dkae135. doi: 10.1093.
    

    >> Share

    
    
35. WEERDENBURG H, Walker H, Curtis N, Duffull S, et al
    Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration.
    J Antimicrob Chemother. 2024;79:1493-1507.
    

    >> Share

    
    
36. CANCELA COSTA A, Kritikos A, Glampedakis E, Da Silva Pereira Clara J, et al
    Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
    J Antimicrob Chemother. 2024;79:1668-1672.
    

    >> Share

    
    
37. CHARFI R, Tazi A, Sereme Y, Plainvert C, et al
    High-level expression of chromosomally encoded SHV-1 beta-lactamase reduces the susceptibility to cefiderocol of clinical isolates of Klebsiella pneumoniae.
    J Antimicrob Chemother. 2024;79:1711-1714.
    

    >> Share

    
    
38. DAABOUL D, Osman M, Kassem II, Yassine I, et al
    Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
    J Antimicrob Chemother. 2024;79:1614-1618.
    

    >> Share

    
    
39. ZHANG LC, Li QY, Zhang YQ, Shan TC, et al
    Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation.
    J Antimicrob Chemother. 2024;79:1697-1705.
    

    >> Share

    
    
40. VALDEZATE S, Medina-Pascual MJ, Villalon P, Garrido N, et al
    Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding.
    J Antimicrob Chemother. 2024;79:1683-1687.
    

    >> Share

    
    
41. RAHMAT ULLAH S, Jamal M, Rahman A, Andleeb S, et al
    Comprehensive insights into Klebsiella pneumoniae: unravelling clinical impact, epidemiological trends and antibiotic-resistance challenges.
    J Antimicrob Chemother. 2024 Jun 4:dkae184. doi: 10.1093.
    

    >> Share

    
    
42. HERMANN L, Schoning V, Drager S, Rentsch K, et al
    Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection.
    J Antimicrob Chemother. 2024 Jul 1:dkae207. doi: 10.1093.
    

    >> Share

    
    
43. SHAH S, Clarke LG, Ludwig J, Burgdorf S, et al
    Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2024 Jul 1:dkae198. doi: 10.1093.
    

    >> Share

    
    

    
    J Bacteriol

44. BARBAREK SC, Shah R, Paul S, Alvarado G, et al
    Lipidomics of homeoviscous adaptation to low temperatures in Staphylococcus aureus utilizing exogenous straight-chain unsaturated fatty acids.
    J Bacteriol. 2024 Jul 2:e0018724. doi: 10.1128/jb.00187.
    

    >> Share

    
    

    
    J Biol Chem

45. SCHNEIDER S, Wirth C, Jank T, Hunte C, et al
    Tyrosine-modifying glycosylation by Yersinia effectors.
    J Biol Chem. 2024;300:107331.
    

    >> Share

    
    

    
    J Infect Dis

46. MUDDE SE, Ammerman NC, Ten Kate MT, Fotouhi N, et al
    Relative contributions of the novel diarylquinoline TBAJ-876 and its active metabolite to the bactericidal activity in a murine model of tuberculosis.
    J Infect Dis. 2024 Jun 28:jiae332. doi: 10.1093.
    

    >> Share

    
    
47. KARLSSON L, Ohrnberg I, Sayyab S, Martinez-Enguita D, et al
    A DNA Methylation Signature from Buccal Swabs to Identify Tuberculosis Infection.
    J Infect Dis. 2024 Jul 4:jiae333. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Chem

48. YU Z, Liang YC, Berton S, Liu L, et al
    Small Molecule Targeting PPM1A Activates Autophagy for Mycobacterium tuberculosis Host-Directed Therapy.
    J Med Chem. 2024 Jul 3. doi: 10.1021/acs.jmedchem.4c00513.
    

    >> Share

    
    

    
    J Med Microbiol

49. ZHANG X, Liew KJ, Cao L, Wang J, et al
    Transcriptome analysis of Candida albicans planktonic cells in response to plasma medicine.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    
50. ARFAOUI A, Rojo-Bezares B, Fethi M, Lopez M, et al
    Molecular characterization of Pseudomonas aeruginosa from diabetic foot infections in Tunisia.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    
51. ZUO XS, Wang QY, Wang SS, Li G, et al
    The role of N-acetylcysteine on adhesion and biofilm formation of Candida parapsilosis isolated from catheter-related candidemia.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    

    
    Lancet

52. HYDE L
    Mobile screening for Ukraine's wartime tuberculosis epidemic.
    Lancet. 2024;403:2771.
    

    >> Share

    
    
53. MCCANN N, Vicentine MP, Pollard AJ
    Towards paratyphoid control: the vital role of the challenge model.
    Lancet. 2024;403:2780-2781.
    

    >> Share

    
    

    
    Nature

54. BELMAN S, Lefrancq N, Nzenze S, Downs S, et al
    Geographical migration and fitness dynamics of Streptococcus pneumoniae.
    Nature. 2024 Jul 3. doi: 10.1038/s41586-024-07626.
    

    >> Share

    
    
55. ZHANG Y, Lai Y, Zhou S, Ran T, et al
    Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587.
    Nature. 2024 Jul 3. doi: 10.1038/s41586-024-07605.
    

    >> Share

    
    
56. COOK GM, McNeil MB
    Blueprints for ATP machinery will aid tuberculosis drug design.
    Nature. 2024 Jul 3. doi: 10.1038/d41586-024-02094.
    

    >> Share

    
    

    
    Pediatr Rev

57. LABUDDE EJ, Lee J
    A Review of Syphilis Infection in Pediatric Patients.
    Pediatr Rev. 2024;45:373-380.
    

    >> Share

    
    

    
    Pediatrics

58. NICOLET N, Bhagia A, Torve M, Tribby K, et al
    The Epidemic of Congenital Syphilis in the Indigenous and Rural Populations of South Dakota.
    Pediatrics. 2024 Jun 27:e2023063823. doi: 10.1542/peds.2023-063823.
    

    >> Share

    
    

    
    PLoS Biol

59. ANTUNES B, Zanchi C, Johnston PR, Maron B, et al
    The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures.
    PLoS Biol. 2024;22:e3002692.
    

    >> Share

    
    

    
    PLoS Negl Trop Dis

60. ROBINSON A, Versteeg B, Abdurahman OS, Clatworthy I, et al
    Field- and laboratory-based studies on correlates of Chlamydia trachomatis transmission by Musca sorbens: Determinants of fly-eye contact and investigations into fly carriage of elementary bodies.
    PLoS Negl Trop Dis. 2024;18:e0012280.
    

    >> Share

    
    
61. AHMMED F, Khanam F, Islam MT, Kim DR, et al
    Spatial and temporal clustering of typhoid fever in an urban slum of Dhaka City: Implications for targeted typhoid vaccination.
    PLoS Negl Trop Dis. 2024;18:e0012273.
    

    >> Share

    
    
62. MUSUMECI S, Kruse A, Chappuis F, Ostergaard Jensen T, et al
    Neglected etiologies of prolonged febrile illnesses in tropical and subtropical regions: A systematic review.
    PLoS Negl Trop Dis. 2024;18:e0011978.
    

    >> Share

    
    
63. MYLONA E, Pham Thanh D, Keane JA, Dongol S, et al
    A retrospective investigation of the population structure and geospatial distribution of Salmonella Paratyphi A in Kathmandu, Nepal.
    PLoS Negl Trop Dis. 2024;18:e0011864.
    

    >> Share

    
    
64. FERREIRA DA CUNHA NETO J, da Silva Rocha WP, Makris G, Sandoval-Denis M, et al
    Fusarioid keratitis and other superficial infections: A 10-years prospective study from Northeastern Brazil.
    PLoS Negl Trop Dis. 2024;18:e0012247.
    

    >> Share

    
    

    
    PLoS One

65. DE CARVALHO RR, Carvalho F, Oliveira EB, Souza da Silva R, et al
    Doubts about the diagnosis and treatment of syphilis in pregnancy among primary care professionals in a telehealth service.
    PLoS One. 2024;19:e0306192.
    

    >> Share

    
    
66. THOMAS LF, Clontz D, Nunez CM, Dittmar RO, et al
    Evaluating the transmission dynamics and host competency of aoudad (Ammotragus lervia) experimentally infected with Mycoplasma ovipneumoniae and leukotoxigenic Pasteurellaceae.
    PLoS One. 2024;19:e0294853.
    

    >> Share

    
    
67. VELAPPAN N, Biryukov SS, Rill NO, Klimko CP, et al
    Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential.
    PLoS One. 2024;19:e0305034.
    

    >> Share

    
    
68. WORKU M, Tessema B, Ferede G, Ochieng L, et al
    Campylobacter jejuni and Campylobacter coli infection, determinants and antimicrobial resistance patterns among under-five children with diarrhea in Amhara National Regional State, Northwest Ethiopia.
    PLoS One. 2024;19:e0304409.
    

    >> Share

    
    
69. BHATTACHARJEE A, Hosen MR, Lamisa AB, Ahammad I, et al
    An integrated comparative genomics, subtractive proteomics and immunoinformatics framework for the rational design of a Pan-Salmonella multi-epitope vaccine.
    PLoS One. 2024;19:e0292413.
    

    >> Share

    
    
70. PALACKDHARRY CS, Wottrich S, Dienes E, Bydon M, et al
    Correction: The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).
    PLoS One. 2024;19:e0306765.
    

    >> Share

    
    
71. PALACIOS CF, Chowdhary V, Hao R, Danve A, et al
    Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?
    PLoS One. 2024;19:e0306337.
    

    >> Share

    
    
72. TONGTOYAI J, Cherdtrakulkiat T, Girdthep N, Masciotra S, et al
    Data quality assessment of the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), Thailand, 2015-2021.
    PLoS One. 2024;19:e0305296.
    

    >> Share

    
    
73. ROBB AR, Ure R, Chaput DL, Foster G, et al
    Emergence of novel methicillin resistant Staphylococcus pseudintermedius lineages revealed by whole genome sequencing of isolates from companion animals and humans in Scotland.
    PLoS One. 2024;19:e0305211.
    

    >> Share

    
    
74. ALLAIRE P, Elsayed NS, Berg RL, Rose W, et al
    Phenome-wide association study identifies new clinical phenotypes associated with Staphylococcus aureus infections.
    PLoS One. 2024;19:e0303395.
    

    >> Share

    
    
75. IRANI SHEMIRANI M
    Transcriptional markers classifying Escherichia coli and Staphylococcus aureus induced sepsis in adults: A data-driven approach.
    PLoS One. 2024;19:e0305920.
    

    >> Share

    
    
76. XIAN X, Li L, Ye J, Mo W, et al
    Betaine and I-LG may have a predictive value for ATB: A causal study in a large European population.
    PLoS One. 2024;19:e0306752.
    

    >> Share

    
    

    
    PLoS Pathog

77. AGGOR FEY, Bertolini M, Coleman BM, Taylor TC, et al
    Combinatorial actions of IL-22 and IL-17 drive optimal immunity to oral candidiasis through SPRRs.
    PLoS Pathog. 2024;20:e1012302.
    

    >> Share

    
    
78. ZHANG Y, Li B, Hong Y, Luo P, et al
    Histone demethylase JMJD2D protects against enteric bacterial infection via up-regulating colonic IL-17F to induce beta-defensin expression.
    PLoS Pathog. 2024;20:e1012316.
    

    >> Share

    
    

    
    Science

79. WEIMANN A, Dinan AM, Ruis C, Bernut A, et al
    Evolution and host-specific adaptation of Pseudomonas aeruginosa.
    Science. 2024;385:eadi0908.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share